Chang Xinxia, Chen Yufeng, Cui Daixun, Wang Yufei, Zhou Yingjia, Zhang Xiao, Tang Genxiong
Key Laboratory of Antibody Technique of National Health Commission, Jiangsu Province Engineering Research Center of Antibody Drug, School of Basic Medicine, Nanjing Medical University, 101 Longmian Road, Nanjing, 211166, Jiangsu, People's Republic of China.
School of Stomatology, Nanjing Medical University, Nanjing, 211166, Jiangsu, People's Republic of China.
Med Oncol. 2023 Feb 19;40(3):98. doi: 10.1007/s12032-023-01962-6.
Oral squamous cell carcinoma (OSCC), main head and neck squamous cell carcinomas (HNSCCs), remains a global health concern with unknown pathogenesis. Veillonella parvula NCTC11810 was observed to decrease in saliva microbiome of OSCC patients in this study and the aim was to detect the novel role of Veillonella parvula NCTC11810 in regulating the biological characteristics of OSCC through TROP2/PI3K/Akt pathway. Oral microbial community changes of OSCC patients were detected by 16S rDNA gene sequencing technology. CCK8 assay, Transwell assay, and Annexin V-FITC/PI staining were used for proliferation, invasion, and apoptosis analysis of OSCC cell lines. Expression of proteins were determined by Western blotting analysis. Veillonella parvula NCTC11810 showed decreased in saliva microbiome of TROP2 high-expressed OSCC patients. Culture supernatant of Veillonella parvula NCTC11810 promoted the apoptosis and inhibited the proliferation and invasion ability of HN6 cells, while sodium propionate (SP), the main metabolite of Veillonella parvula NCTC11810, played a similar role through the inhibition of TROP2/PI3K/Akt pathway. Studies above supported the proliferation-inhibiting, invasion-inhibiting, and apoptosis-promoting function of Veillonella parvula NCTC11810 in OSCC cells which provided new insights into oral microbiota and their metabolite as a therapeutic method for OSCC patients with TROP2 high expressing.
口腔鳞状细胞癌(OSCC)是主要的头颈部鳞状细胞癌(HNSCC),其发病机制尚不清楚,仍是一个全球关注的健康问题。在本研究中,观察到小韦荣球菌NCTC11810在OSCC患者唾液微生物群中减少,目的是检测小韦荣球菌NCTC11810通过TROP2/PI3K/Akt途径调节OSCC生物学特性的新作用。采用16S rDNA基因测序技术检测OSCC患者口腔微生物群落变化。采用CCK8法、Transwell法和Annexin V-FITC/PI染色法对OSCC细胞系进行增殖、侵袭和凋亡分析。通过蛋白质印迹分析确定蛋白质表达。小韦荣球菌NCTC11810在TROP2高表达的OSCC患者唾液微生物群中减少。小韦荣球菌NCTC11810的培养上清液促进HN6细胞凋亡,抑制其增殖和侵袭能力,而小韦荣球菌NCTC11810的主要代谢产物丙酸钠(SP)通过抑制TROP2/PI3K/Akt途径发挥类似作用。上述研究支持了小韦荣球菌NCTC11810在OSCC细胞中的增殖抑制、侵袭抑制和促凋亡功能,为口腔微生物群及其代谢产物作为TROP2高表达OSCC患者的治疗方法提供了新的见解。